Thu, Jul 10, 2014, 12:09 AM EDT - U.S. Markets open in 9 hrs 21 mins

Recent

% | $
Quotes you view appear here for quick access.

AcelRx Pharmaceuticals, Inc. (ACRX) Message Board

timothyc121855 183 posts  |  Last Activity: Jul 8, 2014 11:30 PM Member since: Jan 11, 2010
  • Reply to

    Breo launch gaining traction-Merrill Lynch

    by equityvaluation Apr 16, 2014 11:21 AM
    timothyc121855 timothyc121855 Apr 22, 2014 12:37 PM Flag

    The stock has corrected 30% on the surprising slow rollout of Breo. Even bullish analysts have been talking out of both sides of their mouths on THRX (" we like it BUT"....). At the big Cowen Healthcare Conference at the beginning of March mgmt. comments caught many in the audience by surprise & from there the stock have done nothing but go down.
    Maybe GSK does something down the road but they clearly are in the driver's seat & see the daily numbers that come in & they have been poor. Plus as anyone can see today they are doing big deals that are taking mgmt.'s time & attention. So maybe the stock has bottomed but the near-term fundamentals have been choppy at best. I see the stock trading back to the $30 level on good news & hopefully move up back to the mid $30s over the balance of the year. I bet most would be surprised to see GSK pay more than $40 on the current outlook. Those looking for more clearly can't justify it on the numbers or the fact that there are no other interested parties.

  • Reply to

    Selling ?

    by beachbumsoon325 Apr 21, 2014 9:29 PM
    timothyc121855 timothyc121855 Apr 22, 2014 12:01 PM Flag

    Beachball would have no clue. The buying is coming out of Stifel today is your answer.

  • timothyc121855 timothyc121855 Apr 20, 2014 9:31 PM Flag

    Nobody is selling----$15 by Jooooone ! Rah rah rah !

ACRX
10.68+0.13(+1.23%)Jul 9 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.